Pharmacotherapy in posttraumatic stress disorder: Historical and clinical considerations and future directions

J. R. Davidson, C. B. Nemeroff

Research output: Contribution to journalArticle

13 Scopus citations


Posttraumatic stress disorder (PTSD) has long been recognized as responsive to drug and somatic treatments. Clinical characteristics and patterns of treatment response were well described in the 1940s. Recent studies indicate that tricyclic antidepressants and monoamine oxidase inhibitors (MAOIs) have specific ameliorative effects on PTSD symptoms, but further work is needed in this regard. Goals of drug therapy are provided and future directions suggested.

Original languageEnglish (US)
Pages (from-to)422-425
Number of pages4
JournalPsychopharmacology bulletin
Issue number3
StatePublished - Dec 1 1989


ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this